MedTrace Logo

COVID-19 Genomic Sequencing for Nosocomial Outbreak Investigations

NCT05411562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-09-19

No results posted yet for this study

Summary

This is a tertiary care hospital-based prospective molecular epidemiology study in Montreal, Canada. When nosocomial transmission was suspected by local infection control teams' investigations, SARS-CoV-2 viral genomic sequencing was performed locally for all putative outbreak cases and contemporary controls. Molecular and conventional epidemiology data were confronted in real time to improve understanding of COVID-19 transmission and reinforce or adapt prevention measures.

Conditions

  • COVID-19
  • Molecular Sequence Variation
  • Nosocomial Infection

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 genomic sequencing

SARS-CoV-2 viral genomic sequencing and phylogenetic analyses

Sponsors & Collaborators

  • Fonds de la Recherche en Santé du Québec

    collaborator OTHER_GOV

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Simon Grandjean Lapierre, MD MSc FRCPC · Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-09
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05411562 on ClinicalTrials.gov